Community/Retail

The Drug Enforcement Administration (DEA) will lead the 11th National Prescription Drug Take-Back Day this weekend.

Tight glucose control tempers insidious progress of diabetes. Nevertheless, lifestyle modifications and metformin monotherapy eventually fail to control blood glucose sufficiently in most patients.

The unlawful actions of a former University of Connecticut pharmacy supervisor allegedly cost the university nearly $38,000.

With spring in full bloom, many are celebrating the blossoming flora, but others are lamenting the yearly onset of their seasonal allergies.

The OTC antacid lansoprazole (Prevacid) could actually be a good candidate for treating tuberculosis.

CVS Health has announced that it has made the opioid overdose reversal medication naloxone available without a prescription at all CVS Pharmacy locations in New Hampshire.

The FDA has granted breakthrough therapy designation to nivolumb (Opdivo) as a potential treatment for recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based therapy.

The FDA is continuing to work with clozapine manufacturers to develop a timeline for the program's full implementation.

Total spending on prescription drugs in the United States on a net price basis is expected to reach up to $400 billion by 2020, a new forecast suggests.

The leading cause of death worldwide is preventable.

I'll be 45 years old in August. If I'm lucky, this is only half time.

Female pharmacists looking to start a family should perhaps consider waiting until they're 30 to have their first child.

Medtronic has launched a new product to help patients with Barrett's esophagus: the Barrx 360 Express radiofrequency ablation balloon catheter.

Erin L. Albert, MBA, PharmD, JD, interviews an exciting and dynamic entrepreneur in the pharmacy industry, Shaun Young, PharmD, MBA, founder of Ardina.

Patients with chronic conditions who receive care from pharmacists may be more likely to reach their blood glucose, blood pressure, and cholesterol goals.

Data by itself may simply be a tool; yet, when applied in the right way, it can be a powerful ally.

Diabetes costs the United States more than $300 billion annually, so concerted efforts are needed to manage this disease.

As STD Awareness Month wraps up, pharmacists should encourage patients to do the same.

Walgreens has agreed to pay $500,000 in penalties, fees, and costs related to misleading advertising practices that led to New York customers being overcharged for products.

The FDA has rejected Chiasma Inc's octreotide (Mycapssa) capsules for the maintenance treatment of adults with acromegaly.

Florida Gulf Coast University is considering opening a pharmacy school, which may be good news for students interested in pharmacy in the Sunshine State.

Ron Lanton, government affairs strategist and president of True North Political Solutions, provides the latest pharmacy industry health care policy update.

Diabetes has the dubious distinction of being the 7th leading cause of death and the leading cause of kidney failure, non-traumatic lower-limb amputations, and blindness in the United States.

Anticholinergic agents commonly used for colds and allergies have been linked with brain atrophy and dysfunction.

Hy-Vee has announced that it is once again partnering with the Pinky Swear Foundation to host six kids triathlon fundraising events across the Midwest this summer.

A pair of FDA final guidance documents may help drug manufacturers reduce the risk of deadly medication errors.

MinuteClinic, the retail medical clinic of CVS Health, has opened its first locations inside Target stores in the Chicago area

Pharmakon Pharmaceuticals Inc is voluntarily recalling all lots of its sterile compounded products due to sterility and quality concerns.

Need help studying for your next exam?

The Generic Pharmaceutical Association applauds the House Appropriations Committee for approving the FY 2017 Agriculture Appropriations funding bill with provisions that would stop the Food and Drug Administration from using federal funds to finalize or implement its Proposed Rule to update generic drug labeling requirements as written.